Featured Stories
Exposure to Common Pesticide May Increase ADHD Risk

Exposure to Common Pesticide May Increase ADHD Risk

A new study has found that exposure to a common household pesticide may increase the risk of attention deficit hyperactivity disorder (ADHD) in children.

Read More

Three Injured, Long Island Railroad Train Hits Car on Tracks

Three Injured When Long Island Railroad Train Hits Car on Tracks

Three people, including a train engineer, were injured on Wednesday when a Long Island Rail Road train hit a livery cab on the tracks west of Wyandanch station, LIRR officials said. LIRR spokesman Salvatore Arena said the driver of the Lincoln Town Car was taken to Good Samaritan Hospital Medical Center ...

Read More

Whistleblower Wins Retaliation - Canaveral National Seashore

Whistleblower Wins Retaliation Lawsuit

A whistleblower who reported misconduct at Canaveral National Seashore has won a retaliation ruling against the U.S. Department of Interior, Florida Today reports.

Read More

Actos Side Effects Lawyers Says Whistleblower Revelations Could Boost Bladder Cancer, Heart Failure Lawsuits

An attorney with a prominent personal injury law firm says an Actos whistleblower lawsuit filed earlier this year could strengthen legal claims alleging the type 2 diabetes medication caused some users to develop bladder cancer and heart failure.

Read More

Study Suggests Hormonal Contraceptives Linked to Brain Tumor

Study Suggests Hormonal Contraceptives Linked to Increased Brain Tumor Risk

A study of Danish women of reproductive age suggests that long-term use of hormonal contraceptives is associated with an increased risk of brain tumors.

Read More

Three Injured, Long Island Railroad Train Hits Car on Tracks

Three Injured When Long Island Railroad Train Hits Car on Tracks

3 people, injured on Wednesday at 1:20 p.m. when a LIRR train hit a livery cab on the tracks west of Wyandanch station. The train engineer, who suffered a shoulder injury.

Read More

FDA Panel Takes up Metal-on-Metal Hip Implant Safety Today

The Food and Drug Administration (FDA) is convening a meeting starting today to help decide the future of metal-on-metal hip implants following high-profile recalls and mounting questions about their overall safety.

Read More

Cancer Groups Call for E-cigarettes Regulation/Research

Two Leading Cancer Groups Issue Call for Regulation of E-cigarettes and Research on Health Risks

In a joint statement, the American Society of Clinical Oncology and the American Association for Cancer Research have called on the federal government to move quickly to regulate e-cigarettes and increase research on their health effects. These leading research and treatment organizations asked the Food and Drug Administration (FDA) to make ...

Read More

Warning for Medtronic InterStim Neurostimulation Devices

Australian Health Agency Issues Warning for Battery Problem with Medtronic InterStim Neurostimulation Devices

Warning for Medtronic InterStim Neurostimulation DevicesTGA has issued a safety warning for InterStim and InterStim II neurostimulation devices, because of possible early depletion of the battery.

Read More

Flight Attendant Uniforms Sickening Flight Attendants, Pilots

American Airlines Flight Attendants and Pilots Complain of Uniform-Related Illnesses

American Airlines flight attendants and pilots are alleging that their uniforms are sickening them due to chemicals in the uniforms.

One American Airlines flight attendant told The New York Post that her uniform may look “sexy” but it is making her sick. She is an American Airline crewmember who has been blogging about the effects the American Airlines-issued uniform policy has had on her health in recent months. The flight attendant has hypothyroidism and alleges that her flight attendant outfit has had adverse effects on her condition, causing health reactions from what she described as “chemicals” in the uniform. “I get sick every time I go to work,” she wrote. “Every time I go to work I feel terrible.” Continue reading

Posted in Defective Products |

Propecia-Related Sexual Dysfunction Linked to Depression

The active ingredient in Propecia is finasteride, known to effectively block the hormone responsible for male pattern baldness, a common genetic form of hair loss. However, a number of studies suggest it may also have damaging effects on a man’s sexual health, including decreased sex drive and erectile problems, according to drugwatch.

Propecia was approved by the U.S. Food and Drug Administration (FDA) in 1997. Before the FDA approval, manufacturer Merck & Co. released clinical trial data concerning the drug’s safety. One study showed that almost four percent of men treated with Propecia reported one or more adverse sexual side effects, compared with about two percent of men given a placebo. Continue reading

Posted in Health Concerns, Pharmaceuticals |

Child Drownings Trigger Pool Safety Campaign

A pool safety campaign has been launched jointly by the U.S. Consumer Product Safety Commission (CPSC) and the Michael Phelps Foundation. Over 75 percent of the drownings and pool-related injuries from 2012 to 2016 involved children under the age of five, according to a recent report from the CPSC.

Since it was formed over seven years ago, the Pool Safely campaign has gathered more than 1,000 partners that aid in public outreach and education to assist parents and families to learn vital safety measures in and around pools and spas. Some of the significant partners involved in the campaign include the National Drowning Prevention Alliance, the U.S. YMCA, the Boys & Girls Clubs of America, the Red Cross, the Boy Scouts of America, and Walmart. The focus of this nationwide initiative is to reduce the number of fatal as well as non-fatal drownings or entrapments in swimming pools. Continue reading

Posted in Accident, Health Concerns |

FDA Warning Letters for Bodybuilding Products Containing Steroid-Like Substances

On June 20, 2017, the U.S. Food and Drug Administration (FDA) posted warning letters to Flex Fitness/Big Dan’s Fitness, AndroPharm, and Hardcore Formulations for illegally marketing products labeled as containing steroid and steroid-like substances and promoted to increase muscle mass and strength.

The products are marketed as dietary supplements but the FDA considers these products unapproved drugs that have not been reviewed for safety and effectiveness.   Continue reading

Posted in Defective Products, Health Concerns, Pharmaceuticals |

FDA Investigates Hepatitis A Linked to Frozen Tuna

The U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC), are assisting state and local officials in assessing the risk of hepatitis A virus exposure from contaminated frozen tuna from Sustainable Seafood Company, Vietnam, and Santa Cruz Seafood Inc., Philippines.

If unvaccinated consumers have consumed the recalled product within the last two weeks, they may need treatment to help prevent hepatitis A virus infection. Continue reading

Posted in Food Poisoning, Health Concerns |

Another Try for MDL for PPI Lawsuits – Kidney Damage Allegations

Proton pump inhibitors (PPIs) such as Nexium, Prilosec, and Prevacid are drugs used in the treatment of acid reflux or heartburn. Plaintiffs have filed lawsuits alleging that these medications caused kidney injuries and have filed a motion to consolidate 172 pending federal lawsuits to a multidistrict litigation (MDL). An MDL is frequently created to streamline a procedure by combining cases with similar complaints to be tried in one court before one judge. This lowers court costs, allows for a faster outcome, and is typically more efficient.

In each of the lawsuits against the drug manufacturers including AstraZeneca, Pfizer, Wyeth, among others, the plaintiffs allege that the drug companies failed to sufficiently warn that ingestion of prescription and over-the-counter (OTC) PPIs could cause “irreparable harm” to the kidneys, according to court documents. Continue reading

Posted in Health Concerns, Nexium, Pharmaceuticals |

More Than 400 Cases in Viagra-Melanoma Multidistrict Litigation

As of May 15, 2017, 428 men are plaintiffs in a Viagra (sildenafil) multidistrict product liability litigation in U.S. District Court for the Northern District of California.

The suit alleges that the “little blue pill,” manufactured by Pfizer, is connected to a significant increase in the risk of melanoma, the most dangerous form of skin cancer. Viagra has been prescribed to millions of men to solve problems with erectile dysfunction. Continue reading

Posted in Health Concerns, Pharmaceuticals, Viagra |

Johnson & Johnson Loses Fourth Transvaginal Mesh Trial

On May 26, 2017, health care giant Johnson & Johnson lost its fourth surgical mesh lawsuit when a Philadelphia jury returned a verdict of $2.16 million against Johnson & Johnson and its Ethicon Women’s Health and Urology division.

Observers see this fourth loss in four trials as a trend in lawsuits over alleged surgical mesh complications. Continue reading

Posted in Defective Medical Devices, Transvaginal mesh |

MusclMasster Recalls Al-ER-G Capsules due to Ephedra

MusclMasster, LLC, is recalling all bottles of Al-Er-G Capsules due to the presence of Ephedra Herb, an ingredient that has been banned by the U.S. Food and Drug Administration (FDA). Dietary supplements that contain ephedrine alkaloids pose a risk of serious health consequences, including heart attack, stroke, and death. These risks are proportionately unreasonable in light of any benefits that may result from their use.

This product was distributed from Wheat Ridge, Colorado, through a wellness center and retail store and does not contain UPC codes or expiration dates. The lot number is 314. The product was shipped to Wyoming, South Carolina, and Washington between 2016 and 2017. Continue reading

Posted in Health Concerns, Product Recalls, Recalled Food Products |

Multicounty Litigation Created for Stryker LFIT V40 Hip Lawsuits

Stryker LFIT V40 Hip Implant Lawsuits Consolidated into Multicounty Litigation

The New Jersey Supreme Court has decided to consolidate state lawsuits over the Stryker LFIT V40 hip implants into a multicounty litigation. Plaintiffs allege injuries from the LFIT Anatomic Cobalt Chromium V40 femoral heads, and allege that device makers failed to warn of the risks. Howmedica Osteonics Corp. has been named as defendant. The product in question is a metal-on-metal hip implant, a category of devices that has become controversial in recent years.

Parker Waichman LLP personal injury attorneys note that metal-on-metal hip implants have come under scrutiny following recalls and thousands of lawsuits. The firm represents numerous clients in metal-on-metal hip implant lawsuits and continues to offer free legal consultations to individuals who have questions about pursuing a case. Continue reading

Posted in Legal News |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.